Hansa Biopharma to Participate in Five Upcoming Investor Conferences During May and June

Hansa Biopharma has been invited to participate in five healthcare conferences during May and June including UBS Global Healthcare Conference, RBC Global Healthcare Conference, ABG Life Science Summit, Redeye Orphan Drug Event and Citi's European Healthcare Conference

News provided by

Hansa Biopharma AB

May 13, 2020, 02:34 ET

LUND, Sweden, May 13, 2020 /PRNewswire/ -- Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG mediated diseases, today announced that the Company's management team will participate in the following upcoming investor conferences:

UBS Global Healthcare Conference on Monday, May 18, 2020, with a presentation at 11:40 AM EST/ 17:40 CET on the same day
RBC Capital Markets Global Healthcare Conference on Tuesday, May 19, 2020
ABG Life Science Summit on Tuesday, May 26, 2020, with a presentation at 12:30 CET on the same day
Redeye Orphan Drug Event on Wednesday, May 27, 2020 with presentation 10:10 CET on the same day.
Citi's European Healthcare Conference Tuesday, June 16, 2020

A link to the presentations and webcasts will be available on the Events & Presentations page of the Company's website at http://www.hansabiopharma.com

Calendar 2020

May 18, 2020	UBS Global Healthcare Conference, NYC (virtual)
May 19, 2020	RBC Global Healthcare Conference, NYC (virtual)
May 26, 2020	ABG Life Science Summit, Stockholm (virtual)
May 27, 2020	Redeye Orphan Drug Event, Stockholm (virtual)
Jun 16, 2020	Citi's European Healthcare Conference, London (virtual)
Jun 23, 2020	Annual General Meeting
Jul 16, 2020	Interim Report Jan-Jul 2020
Sep 16, 2020	Bank of America Merill Lynch Global Healthcare Conf., London
Oct 22, 2020	Interim Report Jan-Sep 2020
Nov 25, 2020	Ökonomisk Ugebrev Life Science Conference, Copenhagen

For further information, please contact:
Klaus Sindahl
Head of Investor Relations
Hansa Biopharma
Mobile: +46(0)709-298 269
E-mail: [email protected]

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/hansa-biopharma-ab/r/hansa-biopharma-to-participate-in-five-upcoming-investor-conferences-during-may-and-june,c3109885

The following files are available for download:

https://mb.cision.com/Main/1219/3109885/1246443.pdf

Hansa Biopharma to participate in five upcoming investor conferences during May and June

SOURCE Hansa Biopharma AB